Scientists Identify Novel Genes Linked to Motor Neuron Disease
July 27, 2016
(Eurekalert) – Published today in Nature Genetics, the study reveals three new risk genes for ALS and one of these – C21orf2 – increases an individual’s risk of developing the dis-ease by 65 per cent. These results could aid the development of personalised treatments for people with ALS by using gene therapy – an approach which involves replacing faulty genes or adding new ones. One in every 400 people will be diagnosed with amyotrophic lateral sclerosis (ALS) at some point in their lives, yet its causes are largely unknown and effective treatments are therefore lacking.